AACR 2017

4 stories · following the connections

Business

Cyclacel Pharmaceuticals Reports First Quarter 2017 Financial Results

By Nasdaq OMXMay 11, 2017, 8:05 PM UTC

Business

Biodesix Presents Data From Three Studies at AACR Annual Meeting

By Nasdaq OMXApr 5, 2017, 12:01 PM UTC

Business

Biodesix Presents Data From Three Studies at AACR Annual Meeting

By Nasdaq OMXApr 5, 2017, 12:01 PM UTC

Business

Cyclacel Presents Identification of Sensitive Target Indications and Synergistic Drug Combinations for Novel PLK1 Inhibitor CYC140

By Nasdaq OMXApr 4, 2017, 5:00 PM UTC